Brain tumour segmentation with incomplete imaging data
Open Access
- 2 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in Brain Communications
- Vol. 5 (2) , fcad118
Abstract
Progress in neuro-oncology is increasingly recognized to be obstructed by the marked heterogeneity—genetic, pathological, and clinical—of brain tumours. If the treatment susceptibilities and outcomes of individual patients differ widely, determined by the interactions of many multimodal characteristics, then large-scale, fully-inclusive, richly phenotyped data—including imaging—will be needed to predict them at the individual level. Such data can realistically be acquired only in the routine clinical stream, where its quality is inevitably degraded by the constraints of real-world clinical care. Although contemporary machine learning could theoretically provide a solution to this task, especially in the domain of imaging, its ability to cope with realistic, incomplete, low-quality data is yet to be determined. In the largest and most comprehensive study of its kind, applying state-of-the-art brain tumour segmentation models to large scale, multi-site MRI data of 1251 individuals, here we quantify the comparative fidelity of automated segmentation models drawn from MR data replicating the various levels of completeness observed in real life. We demonstrate that models trained on incomplete data can segment lesions very well, often equivalently to those trained on the full completement of images, exhibiting Dice coefficients of 0.907 (single sequence) to 0.945 (complete set) for whole tumours and 0.701 (single sequence) to 0.891 (complete set) for component tissue types. This finding opens the door both to the application of segmentation models to large-scale historical data, for the purpose of building treatment and outcome predictive models, and their application to real-world clinical care. We further ascertain that segmentation models can accurately detect enhancing tumour in the absence of contrast-enhancing imaging, quantifying the burden of enhancing tumour with an R2 > 0.97, varying negligibly with lesion morphology. Such models can quantify enhancing tumour without the administration of intravenous contrast, inviting a revision of the notion of tumour enhancement if the same information can be extracted without contrast-enhanced imaging. Our analysis includes validation on a heterogeneous, real-world 50 patient sample of brain tumour imaging acquired over the last 15 years at our tertiary centre, demonstrating maintained accuracy even on non-isotropic MRI acquisitions, or even on complex post-operative imaging with tumour recurrence. This work substantially extends the translational opportunity for quantitative analysis to clinical situations where the full complement of sequences is not available and potentially enables the characterization of contrast-enhanced regions where contrast administration is infeasible or undesirable.Keywords
All Related Versions
Funding Information
- Guarantors of Brain
- National Health Service Topol Digital Fellowship
- Medical Research Council (MR/X00046X/1)
- Wellcome Trust (213038/Z/18/Z)
- University College London
- National Institute for Health Research Biomedical Research Centre
- University College London Hospital National Institute
This publication has 31 references indexed in Scilit:
- Tumour heterogeneity in glioblastoma assessed by MRI texture analysis: a potential marker of survivalBritish Journal of Radiology, 2016
- The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS)IEEE Transactions on Medical Imaging, 2015
- Metrics for evaluating 3D medical image segmentation: analysis, selection, and toolBMC Medical Imaging, 2015
- Toward Quantifying the Prevalence, Severity, and Cost Associated With Patient Motion During Clinical MR ExaminationsJournal of the American College of Radiology, 2015
- Determining the Variability of Lesion Size Measurements from CT Patient Data Sets Acquired under “No Change” ConditionsTranslational Oncology, 2015
- Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working GroupJournal of Clinical Oncology, 2010
- Evaluating Variability in Tumor Measurements from Same-day Repeat CT Scans of Patients with Non–Small Cell Lung CancerRadiology, 2009
- Unified segmentationNeuroImage, 2005
- Image segmentation: methods and applications in diagnostic radiology and nuclear medicineEuropean Journal of Radiology, 1993
- Measures of the Amount of Ecologic Association Between SpeciesEcology, 1945